Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT01402193

Unknown

Study of Arimidex and Radiotherapy Sequencing

Breast Cancer
NCT00436709

Unknown

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Breast Cancer
NCT00699101

Terminated

Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy

Breast Cancer
NCT00027885

Completed

Phase II Bevacizumab + Tax In Advanced Breast Cancer

Breast Cancer
NCT00044993

Completed

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

Breast Cancer
NCT01075802

Completed

Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms (TADE)

Breast Cancer | CYP2D6 Polymorphism
NCT00007904

Completed

Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

Breast Cancer
NCT00008034

Completed

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

Breast Cancer
NCT00019812

Completed

Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2

Breast Cancer
NCT01329068

Unknown

Patient Empowerment by Group Medical Consultations (GMC)

Breast Cancer | BRCA Mutation
NCT01395706

Unknown

ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes

Malignant Neoplasm of Breast
NCT00803556

Completed

Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy

Breast Cancer | Solid Tumor
NCT00263705

Completed

Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study

Breast Cancer | Elderly Patients
NCT00002679

Completed

Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer

Breast Cancer
NCT07273357

Not yet recruiting

Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening (FUTURE)

Geriatric Assessment | Adjuvant Drug Therapy | Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT07098507

Not yet recruiting

De-escalation in Axillary Surgery for Early-stage Breast Cancer (RIDES)

Omitting Sentinel Lymph Node Biopsy in Early-stage Breast Cancer
NCT07071038

Recruiting

Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients (SWIVEL)

Breast Cancer | Early Stage Breast Cancer | Adjuvant Treatment
NCT06926868

Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Breast Neoplasms
NCT06517212

Recruiting

Tirzepatide Weight Loss for MRD+ Early Breast Cancer (TRIM-EBC)

Breast Cancer | Breast Neoplasms | Breast Cancers
NCT06518200

Not yet recruiting

Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support (ATOPE-PRO)

Breast Cancer Female
NCT06492616

Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence (ELEGANT)

Breast Cancer
NCT06106711

Not yet recruiting

The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA). (EVA)

Metastatic Breast Cancer
NCT05301881

Recruiting

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study (COSMO)

Oligoprogressive | Metastatic Cancer | Breast Cancer Invasive
NCT05116449

Recruiting

Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein) (IDSein)

Breast Cancer Female
NCT04059003

Recruiting

CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Breast Neoplasms
NCT01703754

Terminated

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.

Breast Cancer Nos Metastatic Recurrent
NCT03884413

Completed

FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France (FEERIC)

Breast Cancer Female
NCT07044791

Active, not recruiting

Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer

Breast Cancer | Breast Cancer Invasive
NCT03211442

Completed

Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary Events (MEDIRAD-BRACE)

Breast Cancer Female | Cardiac Complications | Acute Coronary Events
NCT01621906

Completed

18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain

Metastatic Breast Cancer to the Brain
NCT03184090

Completed

Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC (BioPER)

Metastatic Breast Cancer
NCT03760653

Withdrawn

Synergic Effects of Physical Activity and Probiotic on Gut Immune System and Quality of Life of Breast Cancer Survivors. (ESICA)

Breast Cancer Females
NCT02154529

Terminated

Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer

HER-2 Positive Breast Cancer | Metastatic Malignant Neoplasm to Brain
NCT04374825

Completed

Optimizing Quality of Life in Women Living With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT03625635

Unknown

Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment

Breast Cancer | Breast Neoplasm
NCT03398057

Completed

Effect of Health Education on Female Teachers' Knowledge and Practices Regarding Early Breast Cancer Detection and Screening in the Jazan Area: A Quasi-Experimental Study

Effect of Health Education Regarding Screening Tools of Breast Cancer
NCT03395561

Unknown

Effects of Green Coffee Extract Supplementation on Adropin, Irisin, Vaspine,Systemic Inflammation and Oxidative Stress in Breast Cancer Survivors

Breast Cancer Survivors
NCT00646555

Completed

Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis

Breast Neoplasms
NCT01885013

Completed

Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients (MYME)

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
NCT00364754

Completed

Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer

Metastatic/Recurrent Breast Cancer
NCT01645059

Completed

Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy (PRIMHER)

Disseminated HER2+ Breast Cancer
NCT06407401

Not yet recruiting

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

Musculoskeletal Pain | Drug-Related Side Effects and Adverse Reactions | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | HER2-negative Breast Cancer | ER+ Breast Cancer
NCT00016276

Terminated

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Inflammatory Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Cardiac Toxicity
NCT05467891

Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR)

HER2-negative Breast Cancer | Locoregional Recurrence | Hormone Receptor-positive Breast Cancer
NCT04692103

Active, not recruiting

Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7 | Primary or Recurrent Breast Carcinoma
NCT01132560

Completed

Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ

Breast Cancer
NCT02464982

Completed

Psycho-esthetic Impact of Tattoo Technology as Part of Mammary Reconstruction After Surgery Against Breast Cancer

Breast Cancer | Right or Left Breast Mammary Reconstruction | Malignant Neoplasm Reconstruction by Tattoo of Areola of Female Breast
NCT02010372

Completed

Optimizing Application And Support Of Immunization Information Systems (OASIS) (OASIS)

Increase in Use of Immunization Registry | Increase in HPV Vaccination Rate
NCT05964504

Recruiting

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Metastatic Breast Cancer | Lobular Breast Carcinoma
NCT04687956

Recruiting

Primary Surgical Prevention of Breast Cancer-related Lymphedema (LYMPHA)

Breast Cancer | Lymphedema | Mastectomy

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations